Home › Research › TREM2 and immune genetics
Gain-of-function Modulation of TREM2 and its Impact on Amyloid-β and Tau Pathologies in Alzheimer's Disease: A Systematic Review and Meta-analysis of Animal Studies
Liao Y, Ye S, Zhao L, Zhou M, Wen Y, Zhu Y, Huang J, Zhang L et al.. Molecular neurobiology, 2026-06-02
Topic: Brain proteins, microglia and lab models
A total of 12 studies were included, with overall moderate risk of bias, mainly due to inadequate randomization and blinding. In APP/PS1 mice, TREM2 overexpression significantly reduced Aβ plaque number (SMD = - 0.87; 95% CI, - 1.28 to - 0.47) and plaque area (SMD = - 0.98; 95% CI, - 1.46 to - 0.50), with more pronounced effects observed in younger mice (≤ 7 months), where reductions in insoluble Aβ42 were also observed; phosphorylated Tau levels decreased as well. Our findings reveal that therapeutic efficacy is governed by disease stage, model pathological complexity, and intervention mode.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Liao, Y., Ye, S., Zhao, L., Zhou, M., Wen, Y., Zhu, Y., et al. (2026). Gain-of-function Modulation of TREM2 and its Impact on Amyloid-β and Tau Pathologies in Alzheimer's Disease: A Systematic Review and Meta-analysis of Animal Studies. Molecular neurobiology. https://doi.org/10.1007/s12035-026-05925-6
Vancouver
Liao Y, Ye S, Zhao L, Zhou M, Wen Y, Zhu Y, et al. Gain-of-function Modulation of TREM2 and its Impact on Amyloid-β and Tau Pathologies in Alzheimer's Disease: A Systematic Review and Meta-analysis of Animal Studies. Molecular neurobiology. 2026. doi:10.1007/s12035-026-05925-6. PMID: 42230432.
BibTeX
@article{liao2026-42230432,
author = {Liao, Y. and Ye, S. and Zhao, L. and Zhou, M. and Wen, Y. and Zhu, Y. and Huang, J. and Zhang, L. and others},
title = {{Gain-of-function Modulation of TREM2 and its Impact on Amyloid-β and Tau Pathologies in Alzheimer's Disease: A Systematic Review and Meta-analysis of Animal Studies}},
journal = {Molecular neurobiology},
year = {2026},
doi = {10.1007/s12035-026-05925-6},
pmid = {42230432},
url = {https://doi.org/10.1007/s12035-026-05925-6}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- A total of 12 studies were included, with overall moderate risk of bias, mainly due to inadequate randomization and blinding.
- In APP/PS1 mice, TREM2 overexpression significantly reduced Aβ plaque number (SMD = - 0.87; 95% CI, - 1.28 to - 0.47) and plaque area (SMD = - 0.98; 95% CI, - 1.46 to - 0.50), with more pronounced effects observed in younger mice (≤ 7 months), where reductions in insoluble Aβ42 were also observed; phosphorylated Tau levels decreased as well.
- Our findings reveal that therapeutic efficacy is governed by disease stage, model pathological complexity, and intervention mode.
Why it matters
Pooling 12 animal studies, this meta-analysis found that boosting TREM2, a receptor on microglia (the brain's immune cells), reduced amyloid plaque number and area in APP/PS1 mice, with stronger effects in younger mice; phosphorylated tau also fell. Overall risk of bias was moderate, mainly because of inadequate randomization and blinding. Because these are mouse results, they point to TREM2 as a possible treatment target whose benefit may depend on disease stage, not to a proven therapy for people.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designsystematic review
- Participants12
- Evidence strengthHigh
How this study scored 50/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Molecular neurobiology) |
| Journal's citation record | 2 / 4 | Molecular Neurobiology: journal h-index 176 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 1 / 4 | 12 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Yuhuan Xie: h-index 16 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Yunnan University of Traditional Chinese Medicine: institution h-index 102 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42230432) |
| Free to read | 2 / 2 | Free to read |
| Total | 50 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1007/s12035-026-05925-6
- PubMed: 42230432
- Original source →
- Free full text: Molecular Neurobiology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 37.
Related studies in TREM2 and immune genetics
Also tagged “r47h”
363 studies in the library carry the topic tag “r47h”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 363 tagged studies.